Concepedia

Nao Muraoka

NM

Statistics

Publications

4

Citations

111

H-Index

4

Active since

2018

Affiliations

Shizuoka Cancer Center(Current)

Kobe City Medical Center General Hospital

Mie University

Municipal Hirakata City Hospital

Toho University

Nao Muraoka is an author at Shizuoka Cancer Center specializing in oncology pharmacotherapy, anticoagulant therapy, and venous thromboembolism.

ORCID

Publications per year

2018–2024

4

Publications

4

Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial

Yugo Yamashita, Takeshi Morimoto, Nao Muraoka et al. · Circulation · 2023 · 60 citations

, , +17

Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)

Yugo Yamashita, Takeshi Morimoto, Nao Muraoka et al. · Circulation · 2024 · 21 citations · Full text

, , +17

Crizotinib-induced simultaneous multiple cardiac toxicities

Takuya Oyakawa, Nao Muraoka, Kei Iida et al. · Investigational New Drugs · 2018 · 20 citations

, , +12

Home Treatment for Active Cancer Patients With Low-Risk Pulmonary Embolism　― A Predetermined Companion Report From the ONCO PE Trial ―

Ryuki Chatani, Yugo Yamashita, Takeshi Morimoto et al. · Circulation Journal · 2024 · 10 citations · Full text

, , +17

1–4 of 4